| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. | Director | Common Stock | 0 | 11 Mar 2024 | Direct | ||
| Harpoon Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 0 | 11 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024029429-bailes-joseph-s-2024-03-11 | Harpoon Therapeutics, Inc. | 11 Mar 2024 | 4 | $0 | 4 | Director | 11 Mar 2024, 17:16 |
| /report/000120919123056793-bailes-joseph-s-2023-11-27 | Harpoon Therapeutics, Inc. | 27 Nov 2023 | 1 | $0 | 4 | Director | 28 Nov 2023, 16:22 |
| /report/000120919123039401-bailes-joseph-s-2023-06-22 | Harpoon Therapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:28 |
| /report/000120919122039322-bailes-joseph-s-2022-06-22 | Harpoon Therapeutics, Inc. | 22 Jun 2022 | 2 | +$43,999 | 4 | Director | 24 Jun 2022, 18:41 |
| /report/000120919121032968-bailes-joseph-s-2021-05-04-restatement | Harpoon Therapeutics, Inc. | 04 May 2021 | 1 | $0 | 4/A | Director | 14 May 2021, 20:07 |